Michael B. Paumen
Nessuna posizione attualmente
Storia della carriera di Michael B. Paumen
Precedenti posizioni note di Michael B. Paumen
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| BIOLIDICS LIMITED | Amministratore Delegato | - | 23/03/2020 |
| AFFYMETRIX, INC. | Direttore Tecnico/Scientifico/R&S | - | - |
Qiagen, Inc.
 Qiagen, Inc. Miscellaneous Commercial ServicesCommercial Services Qiagen, Inc. provided technologies for separating, purifying and handling nucleic acids. The company was founded in 1988 and was headquartered in Germantown, MD. | Direttore Tecnico/Scientifico/R&S | - | - |
Dx assays Pte Ltd.
 Dx assays Pte Ltd. Medical SpecialtiesHealth Technology Established in 2008, Dx assays is Singapore's first commercial developer of molecular assays. Their company specializes in Nucleic Acid-based Test (NAT) development. They offer highly customizable services in assay design, development and validation for client-provided content in areas such as infectious disease testing, assay integration and development of companion diagnostic assays. Its laboratories are equipped with the state-of-the-art technologies and are operated by highly qualified personnel under the compliance of ISO-13485 : 2003. | Presidente | 01/01/2008 | - |
Formazione di Michael B. Paumen
| The Johannes Gutenberg University of Mainz | Doctorate Degree |
Statistiche
Distribuzione geografica
| Singapore | 3 |
| Stati Uniti | 3 |
| Germania | 2 |
Posizioni
| Chief Tech/Sci/R&D Officer | 2 |
| President | 1 |
| Doctorate Degree | 1 |
Settori
| Health Technology | 4 |
| Commercial Services | 2 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| BIOLIDICS LIMITED | Health Technology |
| Aziende private | 3 |
|---|---|
Dx assays Pte Ltd.
Dx assays Pte Ltd. Medical SpecialtiesHealth Technology Established in 2008, Dx assays is Singapore's first commercial developer of molecular assays. Their company specializes in Nucleic Acid-based Test (NAT) development. They offer highly customizable services in assay design, development and validation for client-provided content in areas such as infectious disease testing, assay integration and development of companion diagnostic assays. Its laboratories are equipped with the state-of-the-art technologies and are operated by highly qualified personnel under the compliance of ISO-13485 : 2003. | Health Technology |
Affymetrix, Inc.
 Affymetrix, Inc. Medical SpecialtiesHealth Technology Affymetrix, Inc. develops, manufactures and sells products and services for genetic analysis. The company was founded by Stephen P. A. Fodor in 1992 and is headquartered in Santa Clara, CA. | Health Technology |
Qiagen, Inc.
Qiagen, Inc. Miscellaneous Commercial ServicesCommercial Services Qiagen, Inc. provided technologies for separating, purifying and handling nucleic acids. The company was founded in 1988 and was headquartered in Germantown, MD. | Commercial Services |
- Borsa valori
- Insiders
- Michael B. Paumen
- Esperienza
